Literature DB >> 10211581

Flavonoids and the inhibition of PKC and PI 3-kinase.

L Gamet-Payrastre1, S Manenti, M P Gratacap, J Tulliez, H Chap, B Payrastre.   

Abstract

Flavonoids provide a large number of interesting natural compounds that are consumed daily and exhibit more or less potent and selective effects on some signaling enzymes as well as on the growth and proliferation of certain malignant cells in vitro. Among the identified signal transducers, phosphoinositide 3-kinase (PI 3-kinase) and protein kinase C (PKC) are now considered key players in many cellular responses including cell multiplication, apoptosis, and transformation. Despite their lack of strict specificity, some flavonoids provide valuable bases for the design of analogues that could be used to specifically block particular isoforms of PI 3-kinase or PKC and their downstream-dependent cellular responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10211581     DOI: 10.1016/s0306-3623(98)00220-1

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  35 in total

1.  Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line.

Authors:  Akhilendra Kumar Maurya; Manjula Vinayak
Journal:  Mol Biol Rep       Date:  2015-08-27       Impact factor: 2.316

2.  Identification of 3-hydroxy-2-(3-hydroxyphenyl)-4H-1-benzopyran-4-ones as isoform-selective PKC-zeta inhibitors and potential therapeutics for psychostimulant abuse.

Authors:  Langtian Yuan; Jin-Soo Seo; Nam Sook Kang; Shahar Keinan; Sarah E Steele; Gregory A Michelotti; William C Wetsel; David N Beratan; Young-Dae Gong; Tong H Lee; Jiyong Hong
Journal:  Mol Biosyst       Date:  2009-05-08

3.  Neuroprotective effect of Pycnogenol® following traumatic brain injury.

Authors:  Stephen W Scheff; Mubeen A Ansari; Kelly N Roberts
Journal:  Exp Neurol       Date:  2012-10-08       Impact factor: 5.330

Review 4.  Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs.

Authors:  Bernice Wright; Jeremy P E Spencer; Julie A Lovegrove; Jonathan M Gibbins
Journal:  Cardiovasc Res       Date:  2012-09-27       Impact factor: 10.787

5.  A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids.

Authors:  Bernice Wright; Leonardo A Moraes; Charles F Kemp; William Mullen; Alan Crozier; Julie A Lovegrove; Jonathan M Gibbins
Journal:  Br J Pharmacol       Date:  2010-02-10       Impact factor: 8.739

Review 6.  Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.

Authors:  Filipa I Baptista; Ana G Henriques; Artur M S Silva; Jens Wiltfang; Odete A B da Cruz e Silva
Journal:  ACS Chem Neurosci       Date:  2014-01-03       Impact factor: 4.418

7.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

8.  Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.

Authors:  Caitlin E Cassidy; William N Setzer
Journal:  J Mol Model       Date:  2009-07-15       Impact factor: 1.810

9.  Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin.

Authors:  Angeliki Xagorari; Charis Roussos; Andreas Papapetropoulos
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

10.  Attenuation of airway smooth muscle contractility via flavonol-mediated inhibition of phospholipase-Cβ.

Authors:  Amy Brown; Jennifer Danielsson; Elizabeth A Townsend; Yi Zhang; Jose F Perez-Zoghbi; Charles W Emala; George Gallos
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-15       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.